Allergy Therapeutics (LON:AGY) Stock Price Passes Above 50 Day Moving Average of $19.20

Allergy Therapeutics plc (LON:AGYGet Rating)’s stock price passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 19.20 ($0.23) and traded as high as GBX 19.75 ($0.24). Allergy Therapeutics shares last traded at GBX 19.75 ($0.24), with a volume of 6,040 shares trading hands.

Allergy Therapeutics Stock Down 1.3 %

The firm has a 50 day simple moving average of GBX 19.25 and a 200-day simple moving average of GBX 21.31. The company has a quick ratio of 3.14, a current ratio of 3.80 and a debt-to-equity ratio of 18.06. The stock has a market cap of £122.38 million and a P/E ratio of -23.75.

Allergy Therapeutics Company Profile

(Get Rating)

Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics.

See Also

Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.